- Amended tender offer statement by Third Party (SC TO-T/A)
20 Outubro 2008 - 4:38PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, DC 20549
SCHEDULE
TO
(Rule 14d-100)
TENDER OFFER STATEMENT UNDER
SECTION 14(D)(1) OR 13(E)(1) OF
THE SECURITIES EXCHANGE ACT OF 1934
Amendment
No. 3
NEVADA
CHEMICALS, INC.
(Name Of Subject Company (Issuer))
CALYPSO
ACQUISITION CORP.
CYANCO
HOLDING CORP.
OCM
PRINCIPAL OPPORTUNITIES FUND IV, L.P.
(Names of Filing
Persons (Offerors))
Common Stock, par value $0.001 per share
(CUSIP Number 64127C 10 7)
Todd E.
Molz
Managing
Director and General Counsel
333 S.
Grand Avenue, 28th Floor
Los
Angeles, CA 90017
Telephone:
(213) 830-6300
(Name, address and
telephone number of person authorized
to receive notices
and communications on behalf of filing persons)
with a copy to:
Dennis M.
Myers, P.C.
Kirkland &
Ellis LLP
200 East
Randolph Drive
Chicago,
IL 60601
Telephone:
(312) 861-2000
CALCULATION
OF FILING FEE
Transaction
Valuation*
|
|
Amount
of Filing Fee**
|
$94,594,979.64
|
|
$3,733.50
|
* Estimated for
purposes of calculating the amount of the filing fee only. The transaction valuation was calculated by
adding the sum of (1) the offer price of $13.37 per share of common stock
multiplied by 7,004,172 shares of common stock, par value $0.001 per share (
Shares
),
of Nevada Chemicals, Inc. (
Nevada Chemicals
) outstanding
as of September 19, 2008 and (2) the offer price of $13.37 minus
$8.28, which is the weighted average exercise price of outstanding options to
acquire Shares multiplied by 21,000, the number of outstanding options as of September 19,
2008.
** The amount of
the filing fee, calculated in accordance with Section 13(e) and Rule 0-11(d) of
the U.S. Securities Exchange Act of 1934, as amended (the
Exchange Act
),
equals $39.30
per million of the
transaction valuation.
x
Check the box if any part of the fee is offset as
provided by Rule 0-11(a)(2) and identify the filing with which the
offsetting fee was previously paid.
Identify the previous filing by registration statement number or the Form or
Schedule and the date of its filing.
Amount
Previously Paid: $3,733.50
|
|
Filing Party:
Calypso Acquisition Corp, Cyanco Holding Corp. and OCM Principal
|
|
|
Opportunities
Fund IV, L.P.
|
Form or
Registration No.: Schedule TO-T
|
|
Date Filed: September 19,
2008
|
o
Check the box if the filing relates solely to preliminary communications made
before the commencement of a tender offer.
Check the appropriate
boxes below to designate any transactions to which the statement relates:
x
third-party tender offer subject to Rule 14d-1.
o
issuer tender offer subject to Rule 13e-4.
o
going-private transaction subject to Rule 13e-3.
x
amendment to Schedule 13D under Rule 13d-2.
Check the following box if the filing is a final
amendment reporting the results of the tender offer:
x
This Amendment No. 3 (
Amendment
No. 3
) amends and supplements the Tender Offer Statement on
Schedule TO originally filed with the US Securities and Exchange Commission (the
Commission
) on September 19,
2008, as amended by Amendment No. 1 to Schedule TO originally filed with
the Commission on September 25, 2008 and Amendment No. 2 to Schedule
TO originally filed with the Commission on October 2, 2008 (as amended,
the
Schedule TO
), by OCM
Principal Opportunities Fund IV, L.P., a Cayman Islands exempted limited
partnership (
OCM
),
Cyanco Holding Corp., a Delaware corporation (
Parent
), and an affiliate of OCM, and
Calypso Acquisition Corp., a Utah corporation
(
Offeror
),
and an affiliate of OCM, relating to the offer by Offeror to purchase all of
the issued and outstanding shares of common stock, par value $0.001 per share
(the
Shares
)
of Nevada Chemicals, Inc., a Utah corporation (
Nevada Chemicals
),
for $13.37 per Share in cash, without interest and less any required
withholding taxes, upon the terms and subject to the conditions set forth in
the Offer to Purchase, dated September 19, 2008 (the
Offer to Purchase
),
and in the related Letter of Transmittal (which, together with any amendments
or supplements to the Offer to Purchase and the Letter of Transmittal, collectively
constitute the
Offer
). The Offer is being made pursuant to the
Agreement and Plan of Merger, dated as of September 5, 2008, by and among
Parent, Offeror and Nevada Chemicals, a copy of which is incorporated by
reference as Exhibit (d)(1) to Schedule TO.
Except as otherwise
indicated in this Amendment No. 3, the information set forth in the
Schedule TO remains unchanged. All capitalized terms used in this Amendment No. 3
without definition have the meanings ascribed to them in the Schedule TO
or the Offer to Purchase.
The information contained in
the Offer to Purchase, including all schedules and annexes to the Offer to
Purchase, is hereby expressly incorporated in this Amendment No. 3 by
reference to all of the applicable items in the Schedule TO, except that such
information is amended and supplemented to the extent specifically provided in
this Amendment No. 3.
Items 1 through 11.
Items 1, 4, 8 and 11 of the Schedule TO, which
incorporate by reference the information contained in the Offer to Purchase,
are hereby amended and supplemented by adding the following text thereto:
The Offer expired at 12:00 midnight, New York City
time, at the end of Friday, October 17, 2008. Following such expiration,
Offeror accepted for payment in accordance with the terms of the Offer all
Shares that were validly tendered and not withdrawn prior to expiration of the
Offer, and payment for such Shares will be made promptly, in accordance with
the terms of the Offer. The Depositary for the Offer has advised that, as of
12:00 midnight, New York City time, at the end of October 17, 2007, a
total of approximately 6,610,541 Shares were validly tendered and not withdrawn
in the offer (including Shares tendered by notices of guaranteed delivery),
representing approximately 93.539% of the outstanding Shares, thus satisfying
the Minimum Condition.
On October 20, 2008, Offeror issued a press
release announcing the completion of the Offer. The full text of the press
release is set forth as Exhibit (a)(6) hereto and is incorporated by
reference herein.
Pursuant to
the terms of the previously announced merger agreement, Cyanco Holding Corp.
and Calypso Acquisition Corp. expect to effect a short-form merger of Calypso
Acquisition Corp. with and into Nevada Chemicals under Utah law, pursuant to
which short-form merger Calypso Acquisition Corp. will be able to effect the
merger without the need for a meeting of Nevada Chemicals shareholders. In the merger, Cyanco Holding Corp. and
Calypso Acquisition Corp. will acquire all other Nevada Chemicals shares at the
same $13.37 per share price, without interest and less any required withholding
taxes, that was paid in the tender offer.
As a result of the merger, Nevada Chemicals will become a wholly-owned
subsidiary of Cyanco Holding Corp. Cyanco
Holding Corp. and Calypso Acquisition Corp. intend to complete the merger as
soon as practicable following the satisfaction of the conditions in their
merger agreement with Nevada Chemicals.
Item 12. Exhibits.
Item 12 of the Schedule TO is hereby amended and
supplemented to add the following exhibit:
(a)(6)
Press Release issued by Calypso Acquisition Corp.,
dated as of October 20, 2008.
2
SIGNATURES
After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated:
October 20, 2008
|
OCM PRINCIPAL OPPORTUNITIES FUND IV, L.P.
|
|
|
|
|
By:
|
OCM PRINCIPAL OPPORTUNITIES FUND
|
|
|
IV GP, L.P.
|
|
|
Its:
|
General Partner
|
|
|
|
|
|
|
By:
|
OCM PRINCIPAL OPPORTUNITIES FUND
|
|
|
IV GP LTD.
|
|
|
Its:
|
General Partner
|
|
|
|
|
|
|
By:
|
OAKTREE CAPITAL MANAGEMENT, L.P.
|
|
|
Its:
|
Director
|
|
|
|
|
|
|
By:
|
/s/ Jordon L. Kruse
|
|
|
Name: Jordon L. Kruse
|
|
|
Its:
Managing
Director
|
|
|
|
|
|
|
By:
|
/s/ Emily Alexander
|
|
|
Name: Emily Alexander
|
|
|
Its:
Senior Vice
President, Legal
|
|
|
|
|
|
CYANCO HOLDING CORP.
|
|
|
|
|
|
By:
|
|
/s/ Jordon L. Kruse
|
|
Name: Jordon
L. Kruse
|
|
Title:
President
|
|
|
|
|
|
CALYPSO ACQUISITION CORP.
|
|
|
|
|
|
By:
|
|
/s/ Jordon L. Kruse
|
|
Name: Jordon
L. Kruse
|
|
Title:
President
|
3
EXHIBIT INDEX
(a)(1)(A)
|
|
Offer to Purchase, dated September 19, 2008.*
|
|
|
|
(a)(1)(B)
|
|
Form of Letter of Transmittal.*
|
|
|
|
(a)(1)(C)
|
|
Form of Notice of Guaranteed Delivery.*
|
|
|
|
(a)(1)(D)
|
|
Form of Letter to Brokers, Dealers, Commercial
Banks, Trust Companies and Other Nominees.*
|
|
|
|
(a)(1)(E)
|
|
Form of Letter to Clients for use by Brokers,
Dealers, Commercial Banks, Trust Companies and Other Nominees.*
|
|
|
|
(a)(5)
|
|
Press Release issued by Calypso Acquisition Corp.,
dated as of September 19, 2008. *
|
|
|
|
(a)(6)
|
|
Press Release issued by Calypso Acquisition Corp.,
dated as of October 20, 2008. **
|
|
|
|
(d)(1)
|
|
Agreement and Plan of Merger, dated as of
September 5, 2008, by and among Calypso Acquisition Corp., Cyanco
Holding Corp. and Nevada Chemicals, Inc.*
|
|
|
|
(d)(2)
|
|
Nondisclosure Agreement, dated as of July 11,
2007, by and between OCM Principal Opportunities Fund IV, L.P. and Nevada
Chemicals, Inc.*
|
|
|
|
(d)(3)
|
|
Support Agreement, dated as of September 5,
2008, by and among Calypso Acquisition Corp., Cyanco Holding Corp. and
Dr. John T. Day.*
|
|
|
|
(d)(4)
|
|
Support Agreement, dated as of September 5,
2008, by and among Calypso Acquisition Corp., Cyanco Holding Corp. and E.
Bryan Bagley.*
|
|
|
|
(d)(5)
|
|
Support Agreement, dated as of September 5,
2008, by and among Calypso Acquisition Corp., Cyanco Holding Corp. and BLA
Irrevocable Investment Trust.*
|
|
|
|
(d)(6)
|
|
Support Agreement, dated as of September 5,
2008, by and among Calypso Acquisition Corp., Cyanco Holding Corp. and M.
Garfield Cook.*
|
|
|
|
(d)(7)
|
|
Support Agreement, dated as of September 5,
2008, by and among Calypso Acquisition Corp., Cyanco Holding Corp. and James
E. Solomon.*
|
|
|
|
(d)(8)
|
|
Support Agreement, dated as of September 5,
2008, by and among Calypso Acquisition Corp., Cyanco Holding Corp. and Nathan
L. Wade.*
|
|
|
|
(g)
|
|
Not applicable.
|
|
|
|
(h)
|
|
Not applicable.
|
*Previously Filed
** Filed herewith.
4
Nevada Chemicals (NASDAQ:NCEM)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Nevada Chemicals (NASDAQ:NCEM)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025